These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013
|
|
|
|
|
OR
|
|
|
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
|
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
|
(Do not check if smaller reporting company)
|
||||
|
|
Page
|
|
|
|
||
|
FINANCIAL STATEMENTS.
|
3
|
|
|
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
|
||
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
11
|
|
|
|
||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
13
|
|
|
|
||
|
CONTROLS AND PROCEDURES.
|
13
|
|
|
|
||
|
|
||
|
|
||
|
RISK FACTORS.
|
13
|
|
|
|
||
|
EXHIBITS.
|
14
|
|
|
15
|
||
|
16
|
||
|
June 30,
2013
(unaudited)
$
|
December 31,
2012
$
|
|
|
ASSETS
|
||
|
|
||
|
Current Assets
|
||
|
Cash
|
9,608
|
12,650
|
|
Prepaid expenses
|
113
|
–
|
|
|
||
|
Total Current Assets
|
9,721
|
12,650
|
|
|
||
|
Other Assets
|
||
|
Deferred financing costs
|
4,310
|
–
|
|
|
||
|
Total Assets
|
14,031
|
12,650
|
|
|
||
|
|
||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||
|
|
||
|
Current Liabilities
|
||
|
Accounts payable and accrued liabilities
|
295,360
|
119,732
|
|
Accounts payable and accrued liabilities – related parties
|
114,121
|
57,219
|
|
Due to related parties
|
300,000
|
300,000
|
|
|
||
|
Total Current Liabilities
|
709,481
|
476,951
|
|
|
||
|
Non-Current Liabilities
|
||
|
Convertible debenture, net of unamortized discount of $31,128
|
1,372
|
–
|
|
|
||
|
Total Liabilities
|
710,853
|
476,951
|
|
|
||
|
Stockholders’ Equity (Deficit)
|
||
|
|
||
|
Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: nil preferred shares
|
–
|
–
|
|
Class A Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 7,500,000 shares
|
7,500
|
7,500
|
|
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 377,203,075 and 376,603,075 shares, respectively
|
377,203
|
376,603
|
|
Additional paid-in capital
|
321,775
|
283,875
|
|
Deficit accumulated during the development stage
|
(1,403,300)
|
(1,132,279)
|
|
|
||
|
Total Stockholders’ Equity (Deficit)
|
(696,822)
|
(464,301)
|
|
|
||
|
Total Liabilities and Stockholders’ Equity (Deficit)
|
14,031
|
12,650
|
|
For the Three
Months Ended
June 30,
2013
$
|
For the Three
Months Ended
June 30,
2012
$
|
For the Six
Months Ended
June 30,
2013
$
|
For the Six
Months Ended
June 30,
2012
$
|
Accumulated from
November 3, 2008
(date of inception)
to June 30,
2013
$
|
|
|
|
|||||
|
Revenue
|
–
|
–
|
–
|
–
|
–
|
|
|
|||||
|
Operating Expenses
|
|||||
|
|
|||||
|
Consulting fees
|
102,750
|
103,500
|
214,500
|
204,000
|
806,750
|
|
General and administrative
|
442
|
20,636
|
3,103
|
37,603
|
100,838
|
|
Management fees
|
–
|
–
|
–
|
–
|
43,727
|
|
Professional fees
|
25,893
|
12,289
|
35,393
|
20,789
|
210,853
|
|
Transfer agent fees
|
82
|
101
|
251
|
101
|
18,859
|
|
|
|||||
|
Total Operating Expenses
|
129,167
|
136,526
|
253,247
|
262,493
|
1,181,027
|
|
|
|||||
|
Loss Before Other Expenses (Income)
|
(129,167)
|
(136,526)
|
(253,247)
|
(262,493)
|
(1,181,027)
|
|
|
|||||
|
Other Expenses (Income)
|
|||||
|
|
|||||
|
Accretion expense
|
–
|
2,758
|
–
|
5,501
|
16,800
|
|
Impairment of intangible assets
|
–
|
–
|
–
|
–
|
92,538
|
|
Interest expense
|
10,377
|
11,218
|
17,774
|
22,408
|
94,017
|
|
Loss (gain) on settlement of debt
|
–
|
–
|
–
|
–
|
18,918
|
|
|
|||||
|
Total Other Expenses (Income)
|
10,377
|
13,976
|
17,774
|
27,909
|
222,273
|
|
|
|||||
|
Net Loss for the Period
|
(139,544)
|
(150,502)
|
(271,021)
|
(290,402)
|
(1,403,300)
|
|
|
|||||
|
Net Loss Per Share, Basic and Diluted
|
–
|
–
|
–
|
–
|
|
|
|
|||||
|
Weighted Average Shares Outstanding
|
377,203,075
|
347,380,000
|
376,885,045
|
347,380,000
|
|
For the Six Months
Ended June 30,
2013
$
|
For the Six Months
Ended June 30,
2012
$
|
Accumulated from
November 3, 2008
(date of inception)
to June 30,
2013
$
|
|
|
Operating Activities
|
|||
|
|
|||
|
Net loss
|
(271,021)
|
(290,402)
|
(1,403,300)
|
|
Adjustment to reconcile net loss to cash used in operating activities:
|
|||
|
Accretion of debt discount
|
1,372
|
5,501
|
18,172
|
|
Amortization of deferred financing costs
|
190
|
–
|
190
|
|
Loss (gain) on settlement of debt
|
–
|
–
|
18,918
|
|
Impairment of intangible assets
|
–
|
–
|
92,538
|
|
Shares issued for management fees
|
6,000
|
–
|
13,000
|
|
Stock-based compensation
|
–
|
–
|
2,227
|
|
Changes in operating assets and liabilities:
|
|||
|
Prepaid expense and deposits
|
(113)
|
6,708
|
(113)
|
|
Accounts payable and accrued liabilities
|
175,628
|
6,633
|
342,967
|
|
Accounts payable and accrued liabilities – related
|
56,902
|
14,959
|
114,121
|
|
Due to related parties
|
–
|
–
|
11,965
|
|
|
|||
|
Net Cash Used in Operating Activities
|
(31,042)
|
(256,601)
|
(789,315)
|
|
|
|||
|
Investing activities
|
|||
|
Acquisition of intangible assets
|
–
|
–
|
(10,000)
|
|
|
|||
|
Net Cash Used by Investing Activities
|
–
|
–
|
(10,000)
|
|
|
|||
|
Financing activities
|
|||
|
Deferred financing costs
|
(4,500)
|
–
|
(4,500)
|
|
Proceeds from convertible debenture
|
32,500
|
–
|
32,500
|
|
Proceeds from loan payable
|
–
|
60,000
|
709,600
|
|
Repayments of loan payable
|
–
|
–
|
(149,449)
|
|
Proceeds from related parties
|
–
|
–
|
2,649
|
|
Repayments to related parties
|
–
|
–
|
(25,000)
|
|
Capital contribution
|
–
|
–
|
200,600
|
|
Proceeds from the issuance of common stock
|
–
|
–
|
42,523
|
|
|
|||
|
Net Cash Provided by Financing Activities
|
28,000
|
60,000
|
808,923
|
|
|
|||
|
Change in Cash
|
(3,042)
|
(196,601)
|
9,608
|
|
Cash, Beginning of Period
|
12,650
|
320,178
|
–
|
|
|
|||
|
Cash, End of Period
|
9,608
|
123,577
|
9,608
|
|
|
|||
|
Supplemental Disclosures
|
|||
|
Interest paid
|
–
|
–
|
–
|
|
Income tax paid
|
–
|
–
|
–
|
|
|
|||
|
Non-cash investing and financing activities
|
|||
|
Debt discount due to beneficial conversion feature
|
32,500
|
–
|
32,500
|
|
Forgiveness of related party debt
|
–
|
–
|
2,649
|
|
Issuance of common shares to settle debt
|
–
|
–
|
580,055
|
|
Issuance of common shares for acquisition of assets
|
–
|
–
|
250,000
|
|
Issuance of preferred shares for acquisition of assets
|
–
|
–
|
7,500
|
|
Issuance of note payable for acquisition of assets
|
–
|
–
|
325,000
|
|
·
|
Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
|
|
·
|
Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
|
|
a)
|
As at June 30, 2013, the Company owes $300,000 (December 31, 2012 - $300,000) to a company controlled by officers and directors of the Company. The amount owing is unsecured, bears interest at 10% per annum, and due on demand. As at June 30, 2013, the Company has recorded accrued interest of $57,096 (December 31, 2012 - $42,219) which has been included in accounts payable and accrued liabilities – related parties.
|
|
b)
|
As at June 30, 2013, the Company owes $18,725 (December 31, 2012 - $nil) to companies under common control by officers and directors of the Company which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.
|
|
c)
|
For the period ended June 30, 2013, the Company incurred $22,500 (December 31, 2012 - $43,500) to the President and CEO of the Company for consulting services. As at June 30, 2013, the Company owes $37,500 (December 31, 2012 - $15,000), which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.
|
|
d)
|
For the period ended June 30, 2013, the Company incurred $800 (December 31, 2012 - $nil) to the President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties.
|
|
a)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On July 18, 2012, the Board of Directors reviewed the consulting agreement and authorized an increase to the monthly consulting fee from $3,000 to $3,750 per month beginning July 2012. On October 1, 2012, the Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $3,000 per month beginning October 2012.
|
|
b)
|
On October 12, 2011, the Company entered into a consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated.
|
|
c)
|
On October 12, 2011, the Company entered into a consulting agreement with the President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On June 10, 2012, the Board of Directors authorized an increase to the monthly consulting fee from $3,000 to $6,000 per month beginning June 2012. On July 18, 2012, the Board of Directors reviewed the consulting agreement and adjusted the monthly consulting fee to $3,750 beginning July 2012.
|
|
d)
|
On January 2, 2013, the Company entered into a consulting agreement with The Holden Group, LLC (the “Consultant”) whereby the Company paid the Consultant $2,000 and issued 600,000 restricted common shares of the Company upon the execution of the agreement as well as pay $500 on each of the first, second and third month anniversaries of the agreement.
|
|
|
June 30,
2013
$
|
December 31,
2012
$
|
|
Current Assets
|
9,721
|
12,650
|
|
Current Liabilities
|
709,481
|
476,951
|
|
Working Capital (Deficit)
|
(699,760)
|
(464,301)
|
|
|
June 30,
2013
$
|
June 30,
2012
$
|
|
Cash Flows from (used in) Operating Activities
|
(31,042)
|
(256,601)
|
|
Cash Flows from (used in) Financing Activities
|
28,000
|
60,000
|
|
Net Increase (decrease) in Cash During Period
|
(3,042)
|
(196,601)
|
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark
Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated
September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and
Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR
dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals
LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated
June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik
Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy
Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
10.17
|
Professional Services Consulting Agreement with the Holden
Group, LLC – June 6, 2013.
|
8-K
|
6/17/13
|
10.1
|
|
|
10.18
|
Convertible Promissory Note – June 7, 2013.
|
8-K
|
6/17/13
|
10.2
|
|
|
10.19
|
Securities Purchase Agreement – June 7, 2013.
|
8-K
|
6/17/13
|
10.3
|
|
|
10.20
|
Convertible Promissory Note – July 15, 2013.
|
8-K
|
7/24/13
|
10.1
|
|
|
10.21
|
Securities Purchase Agreement – July 15, 2013.
|
8-K
|
7/24/13
|
10.2
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal
Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
|
HDS INTERNATIONAL CORP.
|
||
|
(the “Registrant”)
|
||
|
BY:
|
TASSOS RECACHINAS
|
|
|
Tassos Recachinas
|
||
|
President, Principal Executive Officer, Principal Accounting Officer, Principal Financial Officer
|
||
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark
Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated
September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and
Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR
dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals
LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated
June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik
Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy
Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
10.17
|
Professional Services Consulting Agreement with the Holden
Group, LLC – June 6, 2013.
|
8-K
|
6/17/13
|
10.1
|
|
|
10.18
|
Convertible Promissory Note – June 7, 2013.
|
8-K
|
6/17/13
|
10.2
|
|
|
10.19
|
Securities Purchase Agreement – June 7, 2013.
|
8-K
|
6/17/13
|
10.3
|
|
|
10.20
|
Convertible Promissory Note – July 15, 2013.
|
8-K
|
7/24/13
|
10.1
|
|
|
10.21
|
Securities Purchase Agreement – July 15, 2013.
|
8-K
|
7/24/13
|
10.2
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal
Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|